Please assess the completion status of the following clinical trial:

Trial Title: CPAP in Preeclampsia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women 24-37 weeks pregnant~* Singleton pregnancy~* Primiparous and primigravid~* Maternal age 18-45 years~* Diagnosis of preeclampsia by their treating specialist (SBP\>140/90 and proteinuria\>300mg in 24 hours)~Exclusion Criteria:~* A previous diagnosis of hypertension, cardiac, respiratory or renal disease.~* Any regular cardiac or respiratory medications (PRIOR to pregnancy and diagnosis of preeclampsia)~* Current smokers

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Control (Type: NO_INTERVENTION): The control group will not be fitted with CPAP.
- CPAP group (Type: EXPERIMENTAL): The group will wear a CPAP device throughout the night. The mask fits comfortably over the nose and delivers a steady stream of air under slight pressure (auto-set).

Based on this trial design, predict the completion outcome and termination type (if applicable).